• No results found

IL 10 is a key cytokine in psoriasis Proof of principle by IL 10 therapy: a new therapeutic approach

N/A
N/A
Protected

Academic year: 2020

Share "IL 10 is a key cytokine in psoriasis Proof of principle by IL 10 therapy: a new therapeutic approach"

Copied!
13
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 2. Decreasing TNF-� but increasing IL-10 mRNA expression in response to ini-tial conventional psoriasis therapy
Figure 3. Decreasing disease activity during IL-10 therapy. The PASI (27) was determined in three psoriatic patients undergoing IL-10 therapy for 24 d
Figure 5. Marked systemic antipsoriatic effect of intralesional IL-10 administration in patient F
Figure 6. Moderate antipsoriatic effect of nonlesional IL-10 administration in patient B
+6

References

Related documents

The Test Manager is an automated software testing tool is used in day to days testing activities. The Java programming language is used to develop this tool. Such Test Management

Firstly, the focus was on cutting-back welfare services rather than creating new ones; secondly, the probation service and other criminal justice agencies largely concentrated

We hypothesized that celastrol induces cell cycle arrest of gastric cancer cells by modulating miR-21 expression and mTOR signaling pathway in BGC-823 and MGC-803

Here we include several characterizations of these ideals in directed above meet semi lattices and provided a result related to prime separation theorem.. We also include some

Crab community structure was correlated with vegetation structure, and environmental factors were positively correlated with surface water pH, salinity, tree dominance,

The prepared polymeric films were evaluated for uniformity of thickness, uniformity of weight, physical appearance uniformity of drug content, water absorption capacity, in vitro

As such, it is important to examine multiple, successively generated responses over time using verbal fluency tests as they offer a window into the functional organization of

MTT cell viability assay was conducted on 96-well plates (Santacruz Biotechnology, USA), MCF7 Human Breast cancer cells were seeded at 10000 cells/well, 200 μ l of cells in